APCure is a biotechnology company developing Immunotherapy products based on BacVac (for Bacterial Vaccine), an innovative technology that uses a live, harmless, bioengineered bacterial vector to cure cancers. BacVac is a unique technology that reduces tumor defenses and induce a strong anti-tumor immune response. In other words, BacVac teaches the patient own immune system to fight cancer.
View Top Employees from APCure| Website | http://www.apcure.com |
| Revenue | $6 million |
| Employees | 2 (1 on RocketReach) |
| Founded | 2012 |
| Phone | +33 4 26 84 69 63 |
| Technologies |
JavaScript,
HTML,
Font Awesome
+5 more
(view full list)
|
| Industry | Business Services, Biotechnology |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies |
Looking for a particular APCure employee's phone or email?
APCure Questions
The APCure annual revenue was $6 million in 2023.
Laurent Buffat is the CEO of APCure.
1 people are employed at APCure.
APCure is based in Lyon, Auvergne-Rhône-Alpes.
The NAICS codes for APCure are [541, 54171, 54, 541714, 5417].
The SIC codes for APCure are [873, 87].
Top APCure Employees
Related Companies
